Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study

Table 2 Adverse events by umbilical cord mesenchymal stem cell treatment within 12 months ^a

Patient	Adverse events	Severity	Time (days)	Related to MSCT
2	Herpesvirus infection	AE	291	No relation
3	Herpesvirus infection	AE	135	No relation
3	Herpesvirus infection	AE	187	No relation
9	Death	SAE	7	No relation
12	Tuberculosis infection	AE	326	No relation
14	Death	SAE	256	No relation
27	Death	SAE	192	No relation

^aAE, Adverse event; MSCT, Mesenchymal stem cell treatment; SAE, Severe adverse event.

ISSN: 1478-6362